Experimental Drug Shows Early Promise Against Inherited Form of ALS, Trial Indicates

Experimental Drug Shows Early Promise Against Inherited Form of ALS, Trial Indicates An experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in a phase 1/phase 2 clinical trial conducted at Washington University School of Medicine in St. Louis, Massachusetts General Hospital in Boston